The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab (MSB0010718C) in patients with metastatic Merkel cell carcinoma.
 
Howard Kaufman
No Relationships to Disclose
 
Omid Hamid
Consulting or Advisory Role - Merck
Research Funding - Merck (Inst)
 
Sandra P. D'Angelo
No Relationships to Disclose
 
Guojun Yuan
Employment - EMD Serono
Stock and Other Ownership Interests - Cubist
 
Kevin M. Chin
Employment - EMD Serono
 
Shailender Bhatia
Stock and Other Ownership Interests - Halozyme
Honoraria - Genentech; Novartis; Prometheus
Consulting or Advisory Role - Genentech
Speakers' Bureau - Novartis; Prometheus
Research Funding - Bristol-Myers Squibb; EMD Serono; Immune Design; Merck; Novartis; OncoSec
 
Jean-Marie Cuillerot
Employment - Merck KGaA
 
Paul Nghiem
Travel, Accommodations, Expenses - EMD Serono